WuXi Biologics earnings jump as ‘follow and win the molecule’ strategy pays off

--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-02-11 15:42 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Politics, Health, Asia, China, Financial Markets, Drugs, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
Chinese contract drug maker forecasts 46.3 per cent profit rise and signals continued growth despite US political scrutiny
--------------------------------------------------------------------
>>> Read full article at South China Morning Post <<<
<-- Back to Home
< >
[Close]